-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
September 01, 2017 - Publication
Year
Drug RoB 1 Size
(n)
Primary reason
to include:
Secondary reason to
include … (Author/date)
Tables are divided by Key questions. … To assist reviewers, citations were formatted as (Author, Year),
and the reference list (in author order … efficacy, tolerability and safety of nalmefene
as-needed in patients with alcohol dependence: A 1-year … The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort
study.
-
www.ahrq.gov/sites/default/files/2024-01/devine-report.pdf
January 01, 2024 - data obtained from The Everett
Clinic, she estimated the number of ‘prescriptions per provider per year … Grantsmanship
During the first year of her K-08, there was overlap for Dr. Devine’s time on Dr. … Devine has been invited to author a book chapter about using
electronic data to conduct CER as part … This year,
she has been invited to serve in the same role in the Department of Health Services, School … student from the
Public Health Genetics Program, School of Public Health, and is mentoring a second-year
-
digital.ahrq.gov/sites/default/files/docs/page/09-0069-EF_1.pdf
June 01, 2009 - Acknowledgments
The author appreciates the support of Jerome Osheroff, M.D., and Robyn Tamblyn, Ph.D … The description by Osheroff, et al. of what they call the
“five rights” of CDS is a good summary of … A taxonomic
description of computer-based clinical decision
support systems.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
October 18, 2010 - and affects 12
percent of live births in the United States (more than a half a million births per year … For all studies, the following data will be extracted:
• Study characteristics
•
: first author … , year of publication, country of origin, funding
source, study design, study setting, duration of followup … infusion pump type and
manufacturer
Comparison intervention characteristics
•
: intervention description … held concepts of high quality including the following: a
formal randomized controlled study; clear description
-
www.ahrq.gov/sites/default/files/2024-07/cox-carayon-report.pdf
January 01, 2024 - ensure consideration of the issues that learners face during FCR, researchers also
surveyed 172 third-year … .20-22
To understand medical student experiences with FCR, researchers surveyed 172 of 189 third-year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol.pdf
November 10, 2024 - posting, which will be hyperlinked to previous versions; and a table with the date of each
amendment, description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol-amendment.pdf
January 08, 2025 - posting, which will be hyperlinked to previous versions; and a table with the date of each
amendment, description
-
hcup-us.ahrq.gov/reports/statbriefs/sb123.jsp
November 01, 2011 - This means that a person who is admitted to the hospital multiple times in one year will be counted each … For a detailed description of HCUP, more information on the design of the NIS, and methods to calculate
-
www.ahrq.gov/funding/training-grants/hsrguide/hsrguide3.html
October 01, 2014 - When final editing is complete, the proposal should read as if it is the work of a single author. … Specifically, a plan should include a description of skills and characteristics you are looking for in
-
cdsic.ahrq.gov/sites/default/files/2023-07/StakeholderCenter2023Q2Report.pdf
January 01, 2023 - the PC CDS Performance Measurement Framework, methods
and limitations of the review, a high-level description
-
cdsic.ahrq.gov/sites/default/files/2023-06/InnovationCenterQ12023ProgressReportDraft.pdf
January 01, 2023 - a A detailed description of the model can be found in the Q1 report.
-
digital.ahrq.gov/sites/default/files/StakeholderCenter2023Q2Report.pdf
September 01, 2023 - the PC CDS Performance Measurement Framework, methods
and limitations of the review, a high-level description
-
digital.ahrq.gov/sites/default/files/InnovationCenterQ12023ProgressReportDraft.pdf
January 01, 2024 - a A detailed description of the model can be found in the Q1 report.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Rogers.pdf
January 01, 2003 - Was admitted to the VA 4 times in this
year, underwent Fem-pop bypass left. … Author affiliations
Veterans Administration Getting at Patient Safety (GAPS) Center, Cincinnati, OH … Abstract
Introduction
Background
Methods
Discussion
Conclusion
Acknowledgments
Author affiliations … None)
/PDFXOutputCondition ()
/PDFXRegistryName (http://www.color.org)
/PDFXTrapped /Unknown
/Description
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Rivard.pdf
May 01, 2004 - Modifications to VA data elements
To create a database for fiscal year (FY) 2001, we used all PTF files … 6.3%
Death:
Died in hospital 3.6% 3.9%
* Mean number of hospitalizations per patient per year … Author affiliations
Veterans Administration Center for Health Quality, Outcomes, and Economics Research … Abstract
Introduction
Methods
Results
Discussion
Conclusion
Acknowledgments
Author affiliations … None)
/PDFXOutputCondition ()
/PDFXRegistryName (http://www.color.org)
/PDFXTrapped /Unknown
/Description
-
hcup-us.ahrq.gov/reports/statbriefs/sb133.jsp
May 01, 2012 - This means that a person who is admitted to the hospital multiple times in one year will be counted each … For a detailed description of HCUP, more information on the design of the NIS, and methods to calculate
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/UCajZVxQEKLCgs59HV7ddE
November 01, 2008 - Ann Intern Med. 2008;149:638-658. www.annals.org
For author affiliations, see end of text. … Summary of Newer Fecal Test Studies
Study, Year
(Reference); Patients,
n; Study Quality
Gold Standard … Current author addresses are available at www.annals.org.
References
1. American Cancer Society. … Cancer
658 4 November 2008 Annals of Internal Medicine Volume 149 • Number 9 www.annals.org
Current Author … (Reference)
Study
Design
Population, n Follow-Up Description of Extracolonic Findings
(as Reported
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … The application included a description of the research effort, the proposed
implementation and evaluation … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … The application included a description of the research effort, the proposed
implementation and evaluation … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … The application included a description of the research effort, the proposed
implementation and evaluation … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk